SSY Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SSY Group Ltd with three other
companies in this sector in CHINA :
Haisco Pharmaceutical Group Co Ltd
sales of 3.94 billion Chinese Renmimbi [US$554.50 million]
of which 100%
was Pharmaceutical Industry),
Guangdong Taiantang Pharmaceutical Co Ltd
(4.01 billion Chinese Renmimbi [US$565.15 million]
of which 81%
was Medicine Wholesale & Retail), and
Cisen Pharmaceutical Co Ltd
(4.11 billion Chinese Renmimbi [US$578.60 million]
of which 96%
was Pharmaceutical manufacture).
SSY Group Ltd reported sales of 4.08 billion Chinese Renmimbi (US$574.96 million)
December of 2019.
increase of 15.6%
versus 2018, when the company's sales were 3.53 billion Chinese Renmimbi.
Sales at SSY Group Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 145%).
Sales of Intravenous Infusion Solution and Others saw an increase
15.9% in 2019, from
3.40 billion Chinese Renmimbi to 3.94 billion Chinese Renmimbi.